Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
Actas esp. psiquiatr ; 43(4): 133-141, jul.-ago. 2015. ilus, tab, graf
Article in Spanish | IBECS | ID: ibc-139318

ABSTRACT

Introducción. Este estudio compara la eficacia diferencia de tres grupos de tratamiento para la agorafobia: paroxetina en combinación con terapia cognitivo-conductual, paroxetina en combinación con terapia cognitivo-conductual y exposición de realidad virtual, y un grupo sólo con paroxetina. Metodología. Fueron seleccionados 99 pacientes con agorafobia. Ambos grupos de tratamiento combinado recibieron 11 sesiones de terapia cognitivo-conductual y uno de los grupos también fue expuesto a 4 sesiones de tratamiento de realidad virtual. Los tratamientos se aplicaron en sesiones individuales una vez a la semana durante 3 meses. Resultados. Los tres grupos de tratamiento mostraron mejoras estadísticamente significativas. En algunas de las medidas, los grupos de tratamiento combinado mostraron mayores mejoras y el grupo tratado con la exposición de realidad virtual mostró una mayor capacidad de enfrentar los estímulos fóbicos. Conclusiones. Los tratamientos que combinaron terapia psicofarmacológica y psicológica mostraron una mayor eficacia. Aunque el uso de las nuevas tecnologías dio lugar a una mejoría mayor, siguen existiendo problemas relacionados con la adherencia al tratamiento


Introduction. This study compares the differential efficacy of three groups of treatments for agoraphobia: paroxetine combined with cognitive-behavioral therapy, paroxetine combined with cognitive-behavioral therapy and virtual reality exposure, and a group with only paroxetine. Methodology. 99 patients with agoraphobia were finally selected. Both combined treatment groups received 11 sessions of cognitive-behavioral therapy, and one of the groups was also exposed to 4 sessions of virtual reality treatment. Treatments were applied in individual sessions once a week for 3 months. Results. The three treatment groups showed statistically significant improvements. In some measures, combined treatment groups showed greater improvements. The virtual reality exposure group showed greater improvement confronting phobic stimuli. Conclusions. Treatments combining psychopharmacological and psychological therapy showed greater efficacy. Although the use of new technologies led to greater improvement, treatment adherence problems still remain


Subject(s)
Humans , Virtual Reality Exposure Therapy/methods , Agoraphobia/therapy , Paroxetine/therapeutic use , Cognitive Behavioral Therapy/methods , Case-Control Studies , Treatment Outcome , Combined Modality Therapy/statistics & numerical data , Medication Adherence/statistics & numerical data
2.
Actas Esp Psiquiatr ; 43(4): 133-41, 2015.
Article in English | MEDLINE | ID: mdl-26150057

ABSTRACT

INTRODUCTION: This study compares the differential efficacy of three groups of treatments for agoraphobia: paroxetine combined with cognitive-behavioral therapy, paroxetine combined with cognitive-behavioral therapy and virtual reality exposure, and a group with only paroxetine. METHODOLOGY: 99 patients with agoraphobia were finally selected. Both combined treatment groups received 11 sessions of cognitive-behavioral therapy, and one of the groups was also exposed to 4 sessions of virtual reality treatment. Treatments were applied in individual sessions once a week for 3 months. RESULTS: The three treatment groups showed statistically significant improvements. In some measures, combined treatment groups showed greater improvements. The virtual reality exposure group showed greater improvement confronting phobic stimuli. CONCLUSIONS: Treatments combining psychopharmacological and psychological therapy showed greater efficacy. Although the use of new technologies led to greater improvement, treatment adherence problems still remain.


Subject(s)
Agoraphobia/therapy , Cognitive Behavioral Therapy , Paroxetine/therapeutic use , Selective Serotonin Reuptake Inhibitors/therapeutic use , Virtual Reality Exposure Therapy , Adult , Combined Modality Therapy , Female , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...